Biotech company did not file "baseless" bovine genetic patent suits, judge says

Biotechnology manufacturer STGenetics did not violate US antitrust laws when it accused a bovine genetic services provider of infringing nine of its patents to process sexed semen straws because its claims were not “objectively baseless," a federal judge in Wisconsin has ruled.

Unlock unlimited access to all Global Competition Review content